StockGlow

CRISPR Therapeutics AG (0VRQ.L)

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

$47.88-0.00%
Compare 0VRQ.L with
StockGlow Score
11
Bearish
BearishBullish
1 year ago-14.7%

The outlook

CRISPR Therapeutics AG currently reads as bearish based on below its 50- & 200-day averages, 19% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range19% of the way from its 52-week low to high
Market cap
—
52-wk high
$91.00
52-wk low
$37.58
50-day avg
$71.57
200-day avg
$58.84
Trailing P/E
0.1

Similar stocks

CRSPN.MXCRISPR Therapeutics AG$811.08+0.00%C2RS34.SACRISPR Therapeutics AG$30.45+0.00%1CG.SGCRISPR Therapeutics AG$41.44-1.26%ILU.FIllumina, Inc.$169.00+0.09%22UA.FBioNTech SE$78.70-2.30%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy